Patent · US Active

Stable glucagon peptide formulations

US9173924B2 · kind B2 · utility

1Cited by
1References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2014
Grant dateNov 3, 2015
Priority date
Expiry dateAug 22, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2037/0061
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.